3.57
price down icon5.05%   -0.19
after-market Dopo l'orario di chiusura: 3.56 -0.010 -0.28%
loading

Galectin Therapeutics Inc Borsa (GALT) Ultime notizie

pulisher
06:47 AM

Top Risks to Consider Before Buying Galectin Therapeutics Inc. StockJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - Newser

06:47 AM
pulisher
06:42 AM

Galectin Therapeutics Inc. stock retracement – recovery analysisEarnings Recap Summary & Consistent Income Trade Ideas - Newser

06:42 AM
pulisher
06:23 AM

Comparing Galectin Therapeutics Inc. in custom built stock radarsWeekly Gains Summary & Growth Oriented Trading Recommendations - Newser

06:23 AM
pulisher
05:37 AM

Quantitative breakdown of Galectin Therapeutics Inc. recent moveBull Run & Growth-Oriented Investment Plans - Newser

05:37 AM
pulisher
03:52 AM

What makes Galectin Therapeutics Inc. stock price move sharplyJuly 2025 Breakouts & Verified Entry Point Signals - Newser

03:52 AM
pulisher
03:45 AM

why galectin therapeutics inc. stock attracts strong analyst attentionQuarterly Trade Summary & Community Consensus Trade Alerts - Newser

03:45 AM
pulisher
10:04 AM

Can Galectin Therapeutics Inc. Regain Lost Ground This QuarterMarket Trend Report & Free Real-Time Market Sentiment Alerts - newsyoung.net

10:04 AM
pulisher
09:20 AM

Is Now The Right Time To Buy Galectin Therapeutics Inc (NASDAQ: GALT) Stock? - stocksregister.com

09:20 AM
pulisher
05:59 AM

Signal strength of Galectin Therapeutics Inc. stock in tech scannersExit Point & Momentum Based Trading Ideas - Newser

05:59 AM
pulisher
12:35 PM

Galectin Therapeutics Reports Reduced Losses in Q2 2025 - TipRanks

12:35 PM
pulisher
Aug 14, 2025

GALECTIN THERAPEUTICS INC SEC 10-Q Report - TradingView

Aug 14, 2025
pulisher
Aug 14, 2025

Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2025 and Provides Business Update - Yahoo Finance

Aug 14, 2025
pulisher
Aug 13, 2025

Strategies to average down on Galectin Therapeutics Inc.Market Risk Report & Verified Short-Term Plans - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

What recovery options are there for Galectin Therapeutics Inc.2025 Analyst Calls & Growth Oriented Trading Recommendations - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Combining price and volume data for Galectin Therapeutics Inc.Market Performance Summary & Low Risk Investment Opportunities - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Will Galectin Therapeutics Inc. stock recover after recent dropIPO Watch & Weekly Top Stock Performers List - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

What data driven models say about Galectin Therapeutics Inc.’s futureProfit Target & Low Risk Entry Point Guides - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

How institutional ownership impacts Galectin Therapeutics Inc. stockEarnings Beat & Stepwise Trade Signal Implementation - Newser

Aug 13, 2025
pulisher
Aug 12, 2025

Galectin Therapeutics (NASDAQ:GALT) Share Price Passes Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Aug 12, 2025
pulisher
Aug 12, 2025

Earnings visualization tools for Galectin Therapeutics Inc.Free Capital Growth With Controlled Risk Picks - Newser

Aug 12, 2025
pulisher
Aug 11, 2025

Predicting Galectin Therapeutics Inc. trend using moving averagesChart Scanner for Swing Trade Timing - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Galectin Therapeutics Inc. stock trend outlook and recovery pathLow Drawdown Picks with Weekly Updates - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

What the charts say about Galectin Therapeutics Inc. todayRisk/Reward Optimization Entry Point Analysis - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

How Galectin Therapeutics Inc. stock performs during market volatilityDaily Swing Candidate Analysis with Chart Patterns - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Does Galectin Therapeutics Inc. show high probability of reboundFree Buy Signal Based on Chart Analysis - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Galectin Therapeutics (GALT) Expected to Announce Quarterly Earnings on Tuesday - Defense World

Aug 10, 2025
pulisher
Aug 09, 2025

Galectin GALT 2025Q2 Earnings Preview Upside Potential on Immunotherapy Advancements - AInvest

Aug 09, 2025
pulisher
Aug 08, 2025

Galectin Therapeutics Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView

Aug 08, 2025
$36.35
price down icon 0.41%
$86.92
price up icon 0.88%
$26.69
price up icon 0.91%
$127.80
price up icon 0.04%
$113.52
price up icon 0.73%
biotechnology ONC
$321.36
price up icon 3.77%
Capitalizzazione:     |  Volume (24 ore):